Skip to content

INSM

Insmed Incorporated

Stock

$111.12+2.53 (+2.33%)Close Oct 2, 2026

EBITDA, 2025
−$1.2B

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025−$1.2B—
2024−$872M—
2023−$704M—
2022−$452M—
2021−$366M—
2020−$256M—
2019−$230M—
2018−$304M—
2017−$186M—
2016−$171M—
2015−$116M—
2014−$86M—
2013−$54M—
2012−$42M—
2011−$61M—
2010−$8.0M—
2009−$8.0M—